Farmarcas, administrator of associative pharmacy chains, has consolidated itself as the fourth largest pharmaceutical group in the country. In the November MAT (i.e., in the mobile annual sum of the last 12 months), compared to the previous period, the network grew 44.62%, and in the same cutout of 2018 the revenue was R$ 1,968,438,912.85. With a turnover that reached R$ 2.85 billion, Farmarcas is moving towards reaching 1,100 stores (1,062) and a turnover of R$ 3 billion in 2019. Currently, the company manages 3 brands of the popular model and 8 brands of the conventional pharmaceutical retail model.
Giro News - 18/12/2019
News Item translated automatically
Click HERE to see original